COAG Hemab Therapeutics Holdings, Inc.
$39.15
Hemab Therapeutics Holdings, Inc. (COAG) Earnings News
Earnings press releases, previews and reviews for Hemab Therapeutics Holdings, Inc. (COAG), newest first. Our most recent is preview: Hemab Faces a Narrower Loss Forecast as Souring Sentiment Raises the Stakes.
Tuesday
November 10, 2026
7:00 AM ET
Hemab Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Tuesday
November 3, 2026
2:28 PM ET
Hemab Faces a Narrower Loss Forecast as Souring Sentiment Raises the Stakes
Earnings Whispers · Preview
Tuesday
November 3, 2026
7:00 AM ET
Hemab Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 10, 2026
Tuesday
August 11, 2026
7:00 AM ET
Hemab Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Thursday
May 21, 2026
7:00 AM ET
Hemab Therapeutics Reports First Quarter 2026 Financial Results